Lipitor Generics Watch: FDA Has Yet To Approve ANDA For The World's #1 Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Mylan had pointed to June 28 as the earliest date FDA could approve atorvastatin ANDAs; the agency is continuing discussions with Ranbaxy about its exclusivity status.